Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China · Delayed Price · Currency is CNY 26.11
+1.02 (4.07%)
Mar 27, 2026, 4:00 PM EDT
SHA:688443 Market Cap
SHA:688443 has a market cap or net worth of 9.57 billion as of March 27, 2026. Its market cap has increased by 4.78% in one year.
Market Cap
9.57B
Enterprise Value
8.31B
Revenue
230.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.11
Market Cap Chart
Since June 20, 2023, SHA:688443's market cap has decreased from 12.47B to 9.57B, a decrease of -23.25%. That is a compound annual growth rate of -9.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 9.57B | -4.15% |
| Dec 31, 2025 | 9.99B | 8.57% |
| Dec 31, 2024 | 9.20B | -37.20% |
| Dec 29, 2023 | 14.65B | 17.43% |
| Jun 20, 2023 | 12.47B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hualan Biological Vaccine | 11.41B |
| Aurisco Pharmaceutical | 10.84B |
| Jiangxi Fushine Pharmaceutical | 10.28B |
| Liaoning Chengda Biotechnology | 10.03B |
| HitGen | 9.94B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 9.51B |
| Bio-Thera Solutions | 9.23B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 9.22B |